Phospholipase D treatment enhances gonadotrophin receptor-coupled adenylate cyclase activity in isolated bovine luteal cells

FEBS Lett. 1993 Jul 12;326(1-3):222-6. doi: 10.1016/0014-5793(93)81795-2.

Abstract

LH-stimulated adenylate cyclase activity in membrane preparations of bovine luteal cells could be enhanced by treating the cells with either phospholipase D or its hydrolysis product, phosphatidic acid. Similar augmentary effects were also produced following treatment of the cells with EGF. Moreover, EGF could stimulate the formation of [3H]phosphatidic acid in [3H]myristic acid preloaded cells, suggesting that EGF is able to activate cellular phospholipase D. Also, PMA was able to increase the phosphatidic acid formation with a parallel increase in the adenylate cyclase activity. We propose, therefore, that phosphatidic acid may act as an intracellular second messenger linking EGF-mediated activation of phospholipase D with the sensitization of LH receptor-coupled adenylate cyclase signalling system.

Publication types

  • Comparative Study

MeSH terms

  • Adenylyl Cyclases / metabolism*
  • Animals
  • Cattle
  • Cell Membrane / drug effects
  • Cell Membrane / enzymology
  • Colforsin / pharmacology
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / physiology
  • Female
  • Guanosine Triphosphate / pharmacology
  • Luteal Cells / drug effects
  • Luteal Cells / enzymology*
  • Luteinizing Hormone / pharmacology
  • Phosphatidic Acids / metabolism
  • Phosphatidic Acids / pharmacology
  • Phospholipase D / pharmacology*
  • Receptors, Gonadotropin / physiology*

Substances

  • Phosphatidic Acids
  • Receptors, Gonadotropin
  • Colforsin
  • Epidermal Growth Factor
  • Guanosine Triphosphate
  • Luteinizing Hormone
  • ErbB Receptors
  • Phospholipase D
  • Adenylyl Cyclases